196 related articles for article (PubMed ID: 27354626)
1. Flow Cytometric Analysis of Ovarian Cancer Ascites: Response of Mesothelial Cells and Macrophages to Cancer.
Hashimoto K; Honda K; Matsui H; Nagashima Y; Oda H
Anticancer Res; 2016 Jul; 36(7):3579-84. PubMed ID: 27354626
[TBL] [Abstract][Full Text] [Related]
2. Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.
Carroll MJ; Fogg KC; Patel HA; Krause HB; Mancha AS; Patankar MS; Weisman PS; Barroilhet L; Kreeger PK
Cancer Res; 2018 Jul; 78(13):3560-3573. PubMed ID: 29739756
[TBL] [Abstract][Full Text] [Related]
3. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
4. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models.
Kishikawa T; Sakamoto M; Ino Y; Kubushiro K; Nozawa S; Hirohashi S
Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653
[TBL] [Abstract][Full Text] [Related]
5. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
[TBL] [Abstract][Full Text] [Related]
6. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
[TBL] [Abstract][Full Text] [Related]
8. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings.
Chhieng DC; Yee H; Cangiarella JF; Symmans WF; Cohen JM
Cancer; 2000 Oct; 90(5):299-306. PubMed ID: 11038427
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.
Estermann M; Huang YL; Septiadi D; Ritz D; Liang CY; Jacob F; Drasler B; Petri-Fink A; Heinzelmann-Schwarz V; Rothen-Rutishauser B
PLoS One; 2020; 15(12):e0241500. PubMed ID: 33270665
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources.
Zhang XY; Pettengell R; Nasiri N; Kalia V; Dalgleish AG; Barton DP
J Soc Gynecol Investig; 1999; 6(6):333-40. PubMed ID: 10643588
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Terauchi M; Kajiyama H; Yamashita M; Kato M; Tsukamoto H; Umezu T; Hosono S; Yamamoto E; Shibata K; Ino K; Nawa A; Nagasaka T; Kikkawa F
Clin Exp Metastasis; 2007; 24(5):329-39. PubMed ID: 17487558
[TBL] [Abstract][Full Text] [Related]
14. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
[TBL] [Abstract][Full Text] [Related]
15. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
Satpathy M; Cao L; Pincheira R; Emerson R; Bigsby R; Nakshatri H; Matei D
Cancer Res; 2007 Aug; 67(15):7194-202. PubMed ID: 17671187
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
[TBL] [Abstract][Full Text] [Related]
18. Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.
Uruski P; Mikuła-Pietrasik J; Pakuła M; Budkiewicz S; Drzewiecki M; Gaiday AN; Wierzowiecka M; Naumowicz E; Moszyński R; Tykarski A; Książek K
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921783
[TBL] [Abstract][Full Text] [Related]
19. Mesothelial cells facilitate cancer stem‑like properties in spheroids of ovarian cancer cells.
Shishido A; Mori S; Yokoyama Y; Hamada Y; Minami K; Qian Y; Wang J; Hirose H; Wu X; Kawaguchi N; Nagumo S; Matsuura N; Yamamoto H
Oncol Rep; 2018 Oct; 40(4):2105-2114. PubMed ID: 30066911
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.
Ho CM; Chang SF; Hsiao CC; Chien TY; Shih DT
J Biomed Sci; 2012 Feb; 19(1):23. PubMed ID: 22330345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
